MCM
SILK

Mengis Capital Management’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Mengis Capital Management’s Portfolio SILK Stock Details SILK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-10,225
Closed -$276K – 190
2024
Q2 		$276K Hold
10,225
– – 0.06% 158
2024
Q1 		$187K Sell
10,225
-125
-1% -$1.98K 0.03% 209
2023
Q4 		$127K Sell
10,350
-2,740
-21% -$25.7K 0.02% 168
2023
Q3 		$196K Sell
13,090
-300
-2% -$6.24K 0.04% 164
2023
Q2 		$435K Buy
13,390
+580
+5% +$21.2K 0.09% 122
2023
Q1 		$501K Buy
12,810
+350
+3% +$17.1K 0.11% 114
2022
Q4 		$658K Hold
12,460
– – 0.14% 109
2022
Q3 		$560K Hold
12,460
– – 0.13% 113
2022
Q2 		$453K Buy
12,460
+625
+5% +$22.7K 0.1% 125
2022
Q1 		$488K Sell
11,835
-250
-2% -$8.8K 0.09% 130
2021
Q4 		$514K Hold
12,085
– – 0.1% 129
2021
Q3 		$665K Sell
12,085
-100
-0.8% -$5.23K 0.14% 117
2021
Q2 		$583K Hold
12,185
– – 0.12% 125
2021
Q1 		$617K Sell
12,185
-250
-2% -$13.9K 0.14% 116
2020
Q4 		$783K Buy
12,435
+1,850
+17% +$115K 0.19% 97
2020
Q3 		$711K Sell
10,585
-100
-0.9% -$5.46K 0.2% 97
2020
Q2 		$447K Buy
10,685
+300
+3% +$11.5K 0.13% 114
2020
Q1 		$326K Buy
10,385
+350
+3% +$14K 0.11% 118
2019
Q4 		$405K Buy
+10,035
New +$351K 0.11% 121

Other funds holding SILK

HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Mengis Capital Management's SILK Position: Q3 2024 in Review

Mengis Capital Management sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2024, closing a stake of 10,225 shares — an estimated $276K sold.

Mengis Capital Management first reported a position in SILK in Q4 2019 and held it in 19 quarters. The position peaked at $783K in Q4 2020. 1 fund tracked by Wall St. Rank holds SILK as of Q3 2024.

  • Mengis Capital Management reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Mengis Capital Management sold 10,225 Silk Road Medical, Inc. Common Stock shares in Q3 2024, an estimated $276K.
  • Mengis Capital Management first reported a position in Silk Road Medical, Inc. Common Stock in Q4 2019 and held it in 19 quarters.
  • Mengis Capital Management's Silk Road Medical, Inc. Common Stock position peaked at $783K in Q4 2020.
  • 1 fund tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2024.

Based on Mengis Capital Management's 13F filing for Q3 2024, filed 5 Nov 2024.